Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban.
Sychev DA, Baturina OA, Mirzaev KB, Rytkin E, Ivashchenko DV, Andreev DA, Ryzhikova KA, Grishina EA, Bochkov PO, Shevchenko RV. Sychev DA, et al. Among authors: ryzhikova ka. Pharmgenomics Pers Med. 2020 Jan 23;13:29-37. doi: 10.2147/PGPM.S234910. eCollection 2020. Pharmgenomics Pers Med. 2020. PMID: 32158254 Free PMC article.
Do CYP2C19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients?
Rytkin E, Mirzaev KB, Grishina EA, Smirnov VV, Ryzhikova KA, Sozaeva ZA, Giliarov MI, Andreev DA, Sychev DA. Rytkin E, et al. Among authors: ryzhikova ka. Pharmgenomics Pers Med. 2017 Sep 18;10:243-245. doi: 10.2147/PGPM.S143250. eCollection 2017. Pharmgenomics Pers Med. 2017. PMID: 29075133 Free PMC article.
Effects of CYP2C19 genetic polymorphism on the steady-state concentration of citalopram in patients with major depressive disorder.
Zastrozhin MS, Skryabin VY, Petukhov AE, Torrado MV, Pankratenko EP, Zastrozhina AK, Grishina EA, Ryzhikova KA, Shipitsyn VV, Bryun EA, Sychev DA. Zastrozhin MS, et al. Among authors: ryzhikova ka. Pharmacogenomics J. 2021 Aug;21(4):435-439. doi: 10.1038/s41397-021-00219-7. Epub 2021 Feb 19. Pharmacogenomics J. 2021. PMID: 33608663
Effects of CYP2C19*2 polymorphisms on the efficacy and safety of phenazepam in patients with anxiety disorder and comorbid alcohol use disorder.
Zastrozhin MS, Skryabin VY, Torrado M, Petrovna A, Sorokin AS, Grishina EA, Ryzhikova KA, Bedina IA, Buzik OZ, Chumakov EM, Savchenko LM, Brun EA, Sychev DA. Zastrozhin MS, et al. Among authors: ryzhikova ka. Pharmacogenomics. 2020 Jan;21(2):111-123. doi: 10.2217/pgs-2019-0019. Pharmacogenomics. 2020. PMID: 31957548
How do CYP2C19*2 and CYP2C19*17 genetic polymorphisms affect the efficacy and safety of diazepam in patients with alcohol withdrawal syndrome?
Skryabin VY, Zastrozhin MS, Torrado MV, Grishina EA, Ryzhikova KA, Shipitsyn VV, Galaktionova TE, Sorokin AS, Bryun EA, Sychev DA. Skryabin VY, et al. Among authors: ryzhikova ka. Drug Metab Pers Ther. 2020 Mar 5;35(1):/j/dmdi.2020.35.issue-1/dmpt-2019-0026/dmpt-2019-0026.xml. doi: 10.1515/dmpt-2019-0026. Drug Metab Pers Ther. 2020. PMID: 32134726
The impact of ABCB1 (rs1045642 and rs4148738) and CES1 (rs2244613) gene polymorphisms on dabigatran equilibrium peak concentration in patients after total knee arthroplasty.
Sychev DA, Levanov AN, Shelekhova TV, Bochkov PO, Denisenko NP, Ryzhikova KA, Mirzaev KB, Grishina EA, Gavrilov MA, Ramenskaya GV, Kozlov AV, Bogoslovsky T. Sychev DA, et al. Among authors: ryzhikova ka. Pharmgenomics Pers Med. 2018 Jul 25;11:127-137. doi: 10.2147/PGPM.S169277. eCollection 2018. Pharmgenomics Pers Med. 2018. PMID: 30100750 Free PMC article.
38 results